CV Sciences, Inc. (CVSI)
OTCMKTS · Delayed Price · Currency is USD
0.0500
+0.0100 (25.00%)
Jan 16, 2026, 4:00 PM EST
CV Sciences Market Cap
CV Sciences has a market cap or net worth of $8.61 million as of January 20, 2026. Its market cap has increased by 34.20% in one year.
Market Cap
8.61M
Enterprise Value
9.59M
Revenue
14.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since November 9, 2011, CV Sciences's market cap has increased from 3.71M to 8.61M, an increase of 131.94%. That is a compound annual growth rate of 6.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 8.48M | -25.08% |
| Dec 31, 2025 | 11.31M | 81.66% |
| Dec 31, 2024 | 6.23M | 13.96% |
| Dec 29, 2023 | 5.47M | 10.51% |
| Dec 30, 2022 | 4.95M | -62.06% |
| Dec 31, 2021 | 13.04M | -72.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 723.02M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |